TOKYO -- Swiss pharmaceutical company Novartis plans to start mass production of radiopharmaceuticals, a type of next-generation cancer treatment, in Japan in 2026, Nikkei has learned.
The company will install equipment at its plant in Tamba-Sasayama, Hyogo prefecture to create the country's first radiopharmaceutical mass production facility.
.JPG?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
.JPG?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)